Dysregulated glutamate uptake by astrocytes causes oligodendroglia death in hypoxic perventricular white matter damage

Molecular and Cellular Neuroscience

Volumn 56, Issue , 2013, Pages 342-354

  Murugan, Madhuvika ^a   Ling, Eng Ang ^a   Kaur, Charanjit ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Astrocytes; Developing brain; Glutamate transporters; NMDAR receptors; Oligodendrocytes

Indexed keywords

CALCIUM; CASPASE 3; CASPASE 7; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; GAP JUNCTION PROTEIN; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CALCIUM CELL LEVEL; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MACROGLIA; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; WHITE MATTER LESION;

ASTROCYTES; DEVELOPING BRAIN; GLUTAMATE TRANSPORTERS; NMDAR RECEPTORS; OLIGODENDROCYTES;

ANIMALS; APOPTOSIS; ASTROCYTES; CELL HYPOXIA; CELLS, CULTURED; CEREBRAL CORTEX; CONNEXINS; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; HOMEOSTASIS; HYPOXIA, BRAIN; OLIGODENDROGLIA; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84882793928     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2013.07.005     Document Type: Article

References (54)

1. Allen N.J., Káradóttir R., Attwell D. Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy. Pflugers Arch. 2004, 449:132-142. [Review].
2. Bhat R.V., Axt K.J., Fosnaugh J.S., Smith K.J., Johnson K.A., Hill D.E., et al. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 1994, 17:169-174.
3. Boycott H.E., Dallas M., Boyle J.P., Pearson H.A., Peers C. Hypoxia suppresses astrocyte glutamate transport independently of amyloid formation. Biochem. Biophys. Res. Commun. 2007, 364:100-104.
4. Burzomato V., Frugier G., Pérez-Otaño I., Kittler J.T., Attwell D. The receptor subunits generating NMDA receptor mediated currents in oligodendrocytes. J. Physiol. 2010, 588:3403-3414.
5. Cebers G., Cebere A., Kovács A.D., Högberg H., Moreira T., Liljequist S. Increased ambient glutamate concentration alters the expression of NMDA receptor subunits in cerebellar granule neurons. Neurochem. Int. 2001, 39:151-160.
6. Chan P.H., Chu L. Mechanisms underlying glutamate-induced swelling of astrocytes in primary culture. Acta Neurochir. Suppl. (Wien.) 1990, 51:7-10.
7. Cotrina M.L., Kang J., Lin J.H., Bueno E., Hansen T.W., et al. Astrocytic gap junctions remain open during ischemic conditions. J. Neurosci. 1998, 18:2520-2537.
8. Dallas M., Boycott H.E., Atkinson L., Miller A., Boyle J.P., Pearson H.A., et al. Hypoxia suppresses glutamate transport in astrocytes. J. Neurosci. 2007, 27:3946-3955.
9. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105. [Review].
10. Deng Y.Y., Lu J., Ling E.A., Kaur C. Microglia-derived macrophage colony stimulating factor promotes generation of proinflammatory cytokines by astrocytes in the periventricular white matter in the hypoxic neonatal brain. Brain Pathol. 2010, 20:909-925.
11. Follett P.L., Deng W., Dai W., Talos D.M., Massillon L.J., Rosenberg P.A., et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J. Neurosci. 2004, 24:4412-4420.
12. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 1984, 42:1-11.
13. Gallo V., Ghiani C.A. Glutamate receptors in glia: new cells, new inputs and new functions. Trends Pharmacol. Sci. 2000, 21:252-258. [Review].
14. Garcia-Calvo M., Peterson E.P., Rasper D.M., Vaillancourt J.P., Zamboni R., Nicholson D.W., et al. Purification and catalytic properties of human caspase family members. Cell Death Differ. 1999, 6:362-369.
15. Gras G., Samah B., Hubert A., Léone C., Porcheray F., Rimaniol A.C. EAAT expression by macrophages and microglia: still more questions than answers. Amino Acids 2012, 42:221-229. [Review].
16. Hack M., Merkatz I.R. Preterm delivery and low birth weight-a dire legacy. N. Engl. J. Med. 1995, 333:1772-1774. [Review].
17. Káradóttir R., Cavelier P., Bergersen L.H., Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischemia. Nature 2005, 438:1162-1166.
18. Krebs C., Fernandes H.B., Sheldon C., Raymond L.A., Baimbridge K.G. Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro. J. Neurosci. 2003, 23:3364-3372.
19. +-dependent glutamate transport. Neuroscience 1999, 19:14-16.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
21. López-Bayghen E., Espinoza-Rojo M., Ortega A. Glutamate down-regulates GLAST expression through AMPA receptors in Bergmann glial cells. Brain Res. Mol. Brain Res. 2003, 115:1-9.
22. Maglione M., Tress O., Haas B., Karram K., Trotter J., Willecke K., et al. Oligodendrocytes in mouse corpus callosum are coupled via gap junction channels formed by connexin47 and connexin32. Glia 2010, 58:1104-1117.
23. Magnotti L.M., Goodenough D.A., Paul D.L. Deletion of oligodendrocyte Cx32 and astrocyte Cx43 causes white matter vacuolation, astrocyte loss and early mortality. Glia 2011, 59:1064-1074.
24. Malarkey E.B., Parpura V. Mechanisms of glutamate release from astrocytes. Neurochem. Int. 2008, 52:142-154. [Review].
25. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 1980, 85:890-902.
26. Murugan M., Sivakumar V., Lu J., Ling E.A., Kaur C. Expression of N-methyl d-aspartate receptor subunits in amoeboid microglia mediates production of nitric oxide via NF-κB signaling pathway and oligodendrocyte cell death in hypoxic postnatal rats. Glia 2011, 59:521-539.
27. Nagy J.I., Patel D., Ochalski P.A., Stelmack G.L. Connexin30 in rodent, cat and human brain: selective expression in gray matter astrocytes, co-localization with connexin43 at gap junctions and late developmental appearance. Neuroscience 1999, 88:447-468.
28. Napier I.A., Mohammadi S.A., Christie M.J. Glutamate transporter dysfunction associated with nerve injury-induced pain in mice. J. Neurophysiol. 2012, 107:649-657.
29. Olney J.W. Glutamate, a neurotoxic transmitter. J. Child Neurol. 1989, 4:218-226. [Review].
30. O'Shea R.D. Roles and regulation of glutamate transporters in the central nervous system. Clin. Exp. Pharmacol. Physiol. 2002, 29:1018-1023. [Review].
31. Parys B., Côté A., Gallo V., De Koninck P., Sík A. Intercellular calcium signaling between astrocytes and oligodendrocytes via gap junctions in culture. Neuroscience 2010, 167:1032-1043.
32. Pastor A., Kremer M., Möller T., Kettenmann H., Dermietzel R. Dye coupling between spinal cord oligodendrocytes: differences in coupling efficiency between gray and white matter. Glia 1998, 24:108-120.
33. Peterson B.S., Vohr B., Staib L.H., Cannistraci C.J., Dolberg A., Schneider K.C., et al. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 2000, 284:1939-1947.
34. Phillis, Ren, O'Regan Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate. Brain Res. 2000, 880:224.
35. Pitt D., Nagelmeier I.E., Wilson H.C., Raine C.S. Glutamate uptake by oligodendrocytes: implications for excitotoxicity in multiple sclerosis. Neurology 2003, 61:1113-1120.
36. Rao V.L., Başkaya M.K., Doǧan A., Rothstein J.D., Dempsey R.J. Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J. Neurochem. 1990, 70:2020-2027.
37. Renden R., Taschenberger H., Puente N., Rusakov D.A., Duvoisin R., Wang L.Y., Lehre K.P., von Gersdorff H. Glutamate transporter studies reveal the pruning of metabotropic glutamate receptors and absence of ampa receptor desensitization at mature calyx of held synapses. J. Neurosci. 2005, 25:8482-8497.
38. Robinson M.B., Dowd L.A. Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system. Adv. Pharmacol. 1997, 37:69-115.
39. Rodrigo R., Felipo V. Control of brain glutamine synthesis by NMDA receptors. Front. Biosci. 2007, 12:883-890.
40. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
41. Sagar G.D.V., Larson D.M. Carbenoxolone inhibits junctional transfer and upregulates Connexin43 expression by a protein kinase A-dependent pathway. J. Cell. Biochem. 2006, 98:1543-1551.
42. Salter M.G., Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438:1167-1171.
43. Sánchez-Gómez M.V., Alberdi E., Ibarretxe G., Torre I., Matute C. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J. Neurosci. 2003, 23:9519-9528.
44. Saura J., Tusell J.M., Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189.
45. Shachnai L., Shimamoto K., Kanner B.I. Sulfhydryl modification of cysteine mutants of a neuronal glutamate transporter reveals an inverse relationship between sodium dependent conformational changes and the glutamate-gated anion conductance. Neuropharmacology 2005, 49:862-871.
46. Shimamoto K., Lebrun B., Yasuda-Kamatani Y., Sakaitani M., Shigeri Y., Yumoto N., et al. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol. Pharmacol. 1998, 53:195-201.
47. Sinor J.D., Du S., Venneti S., Blitzblau R.C., Leszkiewicz D.N., Rosenberg P.A., et al. NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro. J. Neurosci. 2000, 20:8831-8837.
48. Sivakumar V., Ling E.A., Lu J., Kaur C. Role of glutamate and its receptors and insulin-like growth factors in hypoxia induced periventricular white matter injury. Glia 2010, 58:507-523.
49. Swanson R.A., Ying W., Kauppinen T.M. Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 2004, 4:193-205. [Review].
50. Teichberg V.I. Glial glutamate receptors: likely actors in brain signaling. FASEB J. 1991, 5:3086-3091.
51. Verkhratsky A., Kirchhoff F. NMDA receptors in glia. Neuroscientist 2007, 13:28-37. [Review].
52. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res. 2001, 50:553-562. [Review].
53. Wang Y., Denisova J.V., Kang K.S., Fontes J.D., Zhu B.T., Belousov A.B. Neuronal gap junctions are required for NMDA receptor-mediated excitotoxicity: implications in ischemic stroke. J. Neurophysiol. 2010, 104:3551-3556.
54. Zagami C.J., O'Shea R.D., Lau C.L., Cheema S.S., Beart P.M. Regulation of glutamate transporters in astrocytes: evidence for a relationship between transporter expression and astrocytic phenotype. Neurotox. Res. 2005, 7:143-149.